Pillar Biosciences, Inc., a leader in oncology-focused next-generation sequencing (NGS) solutions, today announced the launch of the MRDTect™ NPM1 and FLT3 ITD Panel, a research-use-only (RUO), kitted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results